QIAGEN N.V. QGEN just lately introduced two main updates on the COVID-19 testing entrance. Inside Antigen Testing, the corporate introduced its plans to resubmit Emergency Use Authorization utility for its QIAreach SARS-CoV-2 Antigen Take a look at to the FDA within the first quarter of 2021. This www.nasdaq.com
QIAGEN N.V. QGEN just lately introduced two main updates on the COVID-19 testing entrance. Inside Antigen Testing, the corporate introduced its plans to resubmit Emergency Use Authorization utility for its QIAreach SARS-CoV-2 Antigen Take a look at to the FDA within the first quarter of 2021. This
www.nasdaq.com